Bullboard Post History

by 2O2Ovision

Order by:

T.ONC	RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:"The reality is the boats are shaking" If we're going to pick favorites I'll go with the Riddell Family... January 7, 2024
T.ONC	RE:Where is Andrew de Guttadauro View insider profile Individual information Family name ... December 13, 2023
T.ONC	Partial answer to options trainwreck Filing Date Transaction Date Insider Name... December 13, 2023
T.ONC	RE:RE:Roche to acquire Carmot Therapeutics. The billionaire / philantropist Ridell family here in Calgary donated another... December 4, 2023
T.ONC	Ambush trial with Pela for MM The company has never agknowledged this study but nice to see Keytruda is... November 24, 2023
T.ONC	Irene Update with Incyte Finally some some of info on Irene as well. Still recruiting... ... November 24, 2023
T.ONC	The Pela study with Adlai Nortye is now listed as complete We've known that they replicated the results in the Chinese population... November 24, 2023
T.ONC	RE:RE:RE:Matt's options. They had a strike price of $3.44 so it's understandable they let them go... November 20, 2023
T.ONC	RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Andrew's Options I can't vouch for the accuracy of Yahoo or any other of these investor... November 20, 2023
T.ONC	RE:RE:RE:Andrew's Options Simply think it's because they're expiring shortly and one can assume... November 17, 2023
T.ONC	Andrew's Options Maybe they read shareholders concerns after all. Let's hope others follow... November 17, 2023
T.ONC	Institutional Investor Finally revealed. As seen on Fintel amongst others I'm sure ... November 14, 2023
T.ONC	Investor Presentation The presentation on the ONC website has been updated from last quarter for... November 10, 2023
T.ONC	IMACC 2023 Presentation Lost in the press release is the oral presentation in a couple days at IMACC... November 9, 2023
T.ONC	RE:RE:RE:RE:RE:Roche for the buyout I am siding with Roche as well for the simple fact Pancan is likely laying... October 28, 2023
T.ONC	RE:RE:RE:RE:RE:Roche for the buyout In one the recent webcasts (see ONC website) they explained that the pre... October 28, 2023
T.ONC	RE:RE:RE:Roche for the buyout At the very least and for patients' sake, Pancan should be able to move... October 28, 2023
T.ONC	RE:RE:RE:Trucchio @Wainwright... Hey Fox I can't see who you're arguing with but the Sigilon deal is... October 25, 2023
T.ONC	New poster under the website media section They recently added a poster and not sure if it's been brought up on here... October 6, 2023
T.ONC	RE:Adlai Nortye @pelaboost. If you want a fairly detailed and updated picture of AN, have a... September 30, 2023

Become a member today, It's free!

Bullboard Post History

by 2O2Ovision

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:"The reality is the boats are shaking"

RE:Where is Andrew de Guttadauro

Partial answer to options trainwreck

RE:RE:Roche to acquire Carmot Therapeutics.

Ambush trial with Pela for MM

Irene Update with Incyte

The Pela study with Adlai Nortye is now listed as complete

RE:RE:RE:Matt's options.

RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:RE:Andrew's Options

RE:RE:RE:Andrew's Options

Andrew's Options

Institutional Investor

Investor Presentation

IMACC 2023 Presentation

RE:RE:RE:RE:RE:Roche for the buyout

RE:RE:RE:RE:RE:Roche for the buyout

RE:RE:RE:Roche for the buyout

RE:RE:RE:Trucchio @Wainwright...

New poster under the website media section

RE:Adlai Nortye

Featured News Links

Do you want to stay ahead of the markets? See how DealRoom can help.

Featured Company

Pinnacle Silver & Gold Corp V.PINN

Become a member today, It's free!

Sign In

Send my password

Become a member today, It's free!

Bullboard Post History

by 2O2Ovision

Featured News Links

Featured Company